These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
236 related articles for article (PubMed ID: 27732564)
1. Pharmacological targeting of BET proteins inhibits renal fibroblast activation and alleviates renal fibrosis. Xiong C; Masucci MV; Zhou X; Liu N; Zang X; Tolbert E; Zhao TC; Zhuang S Oncotarget; 2016 Oct; 7(43):69291-69308. PubMed ID: 27732564 [TBL] [Abstract][Full Text] [Related]
2. Brd4 inhibition attenuates unilateral ureteral obstruction-induced fibrosis by blocking TGF-β-mediated Nox4 expression. Zhou B; Mu J; Gong Y; Lu C; Zhao Y; He T; Qin Z Redox Biol; 2017 Apr; 11():390-402. PubMed ID: 28063381 [TBL] [Abstract][Full Text] [Related]
3. Src inhibition blocks renal interstitial fibroblast activation and ameliorates renal fibrosis. Yan Y; Ma L; Zhou X; Ponnusamy M; Tang J; Zhuang MA; Tolbert E; Bayliss G; Bai J; Zhuang S Kidney Int; 2016 Jan; 89(1):68-81. PubMed ID: 26444028 [TBL] [Abstract][Full Text] [Related]
4. Blocking the class I histone deacetylase ameliorates renal fibrosis and inhibits renal fibroblast activation via modulating TGF-beta and EGFR signaling. Liu N; He S; Ma L; Ponnusamy M; Tang J; Tolbert E; Bayliss G; Zhao TC; Yan H; Zhuang S PLoS One; 2013; 8(1):e54001. PubMed ID: 23342059 [TBL] [Abstract][Full Text] [Related]
5. Blocking the histone lysine 79 methyltransferase DOT1L alleviates renal fibrosis through inhibition of renal fibroblast activation and epithelial-mesenchymal transition. Liu L; Zou J; Guan Y; Zhang Y; Zhang W; Zhou X; Xiong C; Tolbert E; Zhao TC; Bayliss G; Zhuang S FASEB J; 2019 Nov; 33(11):11941-11958. PubMed ID: 31373855 [TBL] [Abstract][Full Text] [Related]
6. Apamin inhibits renal fibrosis via suppressing TGF-β1 and STAT3 signaling in vivo and in vitro. Gwon MG; An HJ; Gu H; Kim YA; Han SM; Park KK J Mol Med (Berl); 2021 Sep; 99(9):1265-1277. PubMed ID: 34031696 [TBL] [Abstract][Full Text] [Related]
7. Protein arginine methyltransferase 1 mediates renal fibroblast activation and fibrogenesis through activation of Smad3 signaling. Zhu Y; Yu C; Zhuang S Am J Physiol Renal Physiol; 2020 Feb; 318(2):F375-F387. PubMed ID: 31813251 [TBL] [Abstract][Full Text] [Related]
8. MFAP4 deficiency alleviates renal fibrosis through inhibition of NF-κB and TGF-β/Smad signaling pathways. Pan Z; Yang K; Wang H; Xiao Y; Zhang M; Yu X; Xu T; Bai T; Zhu H FASEB J; 2020 Nov; 34(11):14250-14263. PubMed ID: 32905637 [TBL] [Abstract][Full Text] [Related]
9. Pharmacological Inhibition of STAT6 Ameliorates Myeloid Fibroblast Activation and Alternative Macrophage Polarization in Renal Fibrosis. Jiao B; An C; Tran M; Du H; Wang P; Zhou D; Wang Y Front Immunol; 2021; 12():735014. PubMed ID: 34512669 [TBL] [Abstract][Full Text] [Related]
10. NF-κB signaling activation via increases in BRD2 and BRD4 confers resistance to the bromodomain inhibitor I-BET151 in U937 cells. Hishiki K; Akiyama M; Kanegae Y; Ozaki K; Ohta M; Tsuchitani E; Kaito K; Yamada H Leuk Res; 2018 Nov; 74():57-63. PubMed ID: 30300821 [TBL] [Abstract][Full Text] [Related]
11. BET bromodomain proteins are required for glioblastoma cell proliferation. Pastori C; Daniel M; Penas C; Volmar CH; Johnstone AL; Brothers SP; Graham RM; Allen B; Sarkaria JN; Komotar RJ; Wahlestedt C; Ayad NG Epigenetics; 2014 Apr; 9(4):611-20. PubMed ID: 24496381 [TBL] [Abstract][Full Text] [Related]
12. The BET bromodomain inhibitor I-BET151 acts downstream of smoothened protein to abrogate the growth of hedgehog protein-driven cancers. Long J; Li B; Rodriguez-Blanco J; Pastori C; Volmar CH; Wahlestedt C; Capobianco A; Bai F; Pei XH; Ayad NG; Robbins DJ J Biol Chem; 2014 Dec; 289(51):35494-502. PubMed ID: 25355313 [TBL] [Abstract][Full Text] [Related]
13. A novel STAT3 inhibitor, S3I-201, attenuates renal interstitial fibroblast activation and interstitial fibrosis in obstructive nephropathy. Pang M; Ma L; Gong R; Tolbert E; Mao H; Ponnusamy M; Chin YE; Yan H; Dworkin LD; Zhuang S Kidney Int; 2010 Aug; 78(3):257-68. PubMed ID: 20520592 [TBL] [Abstract][Full Text] [Related]
14. Identification of histone deacetylase 8 as a novel therapeutic target for renal fibrosis. Zhang Y; Zou J; Tolbert E; Zhao TC; Bayliss G; Zhuang S FASEB J; 2020 Jun; 34(6):7295-7310. PubMed ID: 32281211 [TBL] [Abstract][Full Text] [Related]
15. Glycolysis inhibitors suppress renal interstitial fibrosis via divergent effects on fibroblasts and tubular cells. Wei Q; Su J; Dong G; Zhang M; Huo Y; Dong Z Am J Physiol Renal Physiol; 2019 Jun; 316(6):F1162-F1172. PubMed ID: 30969803 [TBL] [Abstract][Full Text] [Related]
16. Histone deacetylase 6 inhibition mitigates renal fibrosis by suppressing TGF-β and EGFR signaling pathways in obstructive nephropathy. Chen X; Yu C; Hou X; Li J; Li T; Qiu A; Liu N; Zhuang S Am J Physiol Renal Physiol; 2020 Dec; 319(6):F1003-F1014. PubMed ID: 33103445 [TBL] [Abstract][Full Text] [Related]
17. Critical roles of SMYD2 lysine methyltransferase in mediating renal fibroblast activation and kidney fibrosis. Liu L; Liu F; Guan Y; Zou J; Zhang C; Xiong C; Zhao TC; Bayliss G; Li X; Zhuang S FASEB J; 2021 Jul; 35(7):e21715. PubMed ID: 34143514 [TBL] [Abstract][Full Text] [Related]
18. Inhibitory effects of fasudil on renal interstitial fibrosis induced by unilateral ureteral obstruction. Baba I; Egi Y; Utsumi H; Kakimoto T; Suzuki K Mol Med Rep; 2015 Dec; 12(6):8010-20. PubMed ID: 26498136 [TBL] [Abstract][Full Text] [Related]
19. Activation of Sirtuin-1 Promotes Renal Fibroblast Activation and Aggravates Renal Fibrogenesis. Ponnusamy M; Zhuang MA; Zhou X; Tolbert E; Bayliss G; Zhao TC; Zhuang S J Pharmacol Exp Ther; 2015 Aug; 354(2):142-51. PubMed ID: 26022003 [TBL] [Abstract][Full Text] [Related]
20. Inhibition of Yes-Associated Protein by Verteporfin Ameliorates Unilateral Ureteral Obstruction-Induced Renal Tubulointerstitial Inflammation and Fibrosis. Jin J; Wang T; Park W; Li W; Kim W; Park SK; Kang KP Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33142952 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]